Brain Tumor Epidemiology: Consensus from the Brain Tumor Epidemiology Consortium (BTEC)
By Melissa L. Bondy, Michael E. Scheurer, B. Malmer, Jill S. Barnholtz-Sloan, Faith G. Davis, D. Il’yasova, C. Kruchko, B. McCarthy, P. Rajaraman, J. Schwartzbaum and 6 more. Cancer, 2008
900 citations recorded by the source corpus.
Epidemiologists in the Brain Tumor Epidemiology Consortium (BTEC) have prioritized areas for further research. Although many risk factors have been examined over the past several decades, there are few consistent findings, possibly because of small sample sizes in individual studies and differences between studies in patients, tumor types, and methods of classification. Individual studies generally have lacked samples of sufficient size to examine interactions. A major priority based on available evidence and technologies includes expanding research in genetics and molecular epidemiology of brain tumors. BTEC has taken an active role in promoting understudied groups, such as pediatric brain tumors; the etiology of rare glioma subtypes, such as oligodendroglioma; and meningioma, which, although it is not uncommon, has only recently been registered systematically in the United States. There also is a pressing need for more researchers, especially junior investigators, to study brain tumor epidemiology. However, relatively poor funding for brain tumor research has made it difficult to encourage careers in this area. In this report, BTEC epidemiologists reviewed the group's consensus on the current state of scientific findings, and they present a consensus on research priorities to identify which important areas the science should move to address. Cancer 2008;113(7 suppl):1953–68. © 2008 American Cancer Society.
Subfields: Genetics, Pediatrics, Perinatology and Child Health, Public Health, Environmental and Occupational Health
View Paper: https://www.semanticscholar.org/paper/0aaacf5494e6c5a16c35898a2a46dcb4cd26a394
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- K. Muzaffar
- F. Hanif
- Kahkashan Perveen
- S. Simjee
- S. Malhi
Citations in the corpus
- Glioblastoma Multiforme: A Review of its Epidemiology and Pathogenesis through Clinical Presentation and Treatment (2017, background): “It has also been propose that infection and allergic diseases may have protective effect on GBM which may be due to the activation of immune surveillance mechanism (Fisher et al., 2007; Bondy et al., 2008).”
- Cost of disorders of the brain in Europe 2010. (2011, neutral): “, 2010) and are a diverse group of tumors with marked differences in etiology, treatment and prognosis (Bondy et al., 2008; DeAngelis, 2001; Wrensch et al., 2002).”